ENSEM Therapeutics

Medford, United States

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

$10.0M raised

Oct 2023

Series A

Biotechnology Oncology Therapeutics

Top Investors

Legend StarPavilion CapitalMegaRoboGGV CapitalCBC Group

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ENSEM Therapeutics

How much funding has ENSEM Therapeutics raised?

ENSEM Therapeutics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.

Who are ENSEM Therapeutics's investors?

ENSEM Therapeutics's investors include Legend Star, Pavilion Capital, MegaRobo, GGV Capital, CBC Group.

Where is ENSEM Therapeutics headquartered?

ENSEM Therapeutics is headquartered in Medford, United States.

What does ENSEM Therapeutics do?

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

What stage is ENSEM Therapeutics at?

ENSEM Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 23, 2023.

MLA

"ENSEM Therapeutics — Funding & Investors." VCBacked, October 23, 2023, https://www.vcbacked.co/company/ensem-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2023). ENSEM Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/ensem-therapeutics

Wikipedia (cite web)

{{cite web |title=ENSEM Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ensem-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 23, 2023.

Similar Companies in Biotechnology